A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy Participants
Status:
Completed
Trial end date:
2017-06-16
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the potential drug interaction between danicopan
(ACH-0144471) and midazolam, fexofenadine, and mycophenolate mofetil. This was a 3-part
study, with each part being an open-label, fixed-sequence, 2-treatment study in healthy adult
participants.